Why Are My Hot Flashes Getting Worse? Causes & Tips
Hot flashes intensifying? Learn the most common medical and lifestyle reasons hot flashes worsen, which treatments have the strongest evidence, and when to call your doctor.
Female Orgasmic Disorder: Causes, Diagnosis, and Treatment Options
A guide to female orgasmic disorder (FOD), covering diagnostic criteria, contributing conditions like HSDD and GSM, and evidence-based treatments including flibanserin, ospemifene, pelvic floor PT, and cognitive behavioral therapy.
Adderall XR Appetite & Cravings Changes: What the Evidence Says
A deep dive into how Adderall XR (mixed amphetamine salts) suppresses appetite, alters food cravings, and affects weight, with primary-literature citations, real doses, and practical management strategies.
Adderall XR Muscle Preservation Strategies: A Clinical Guide
Evidence-based strategies to preserve muscle mass while taking Adderall XR (mixed amphetamine salts), including nutrition timing, protein targets, resistance training, and monitoring protocols for prescribers and patients.
Adderall XR Off-Label Uses: Evidence Levels, Doses, and Clinical Considerations
A guide to mixed amphetamine salts (Adderall XR) off-label uses, ranked by evidence level, with specific trial data, doses, and guideline references.
Adderall XR Pre-Surgery Hold Window: What Patients and Clinicians Need to Know
A clinician-level guide to the Adderall XR (mixed amphetamine salts extended-release) pre-surgery hold window, covering timing considerations, pharmacokinetic rationale, anesthesia interactions, and how to plan for ADHD symptoms during the perioperative period.
Why Is Adderall Banned in Europe? US, EU, UK, Canada Rules
Adderall was never approved in the EU or UK; no marketing authorization exists there. It's FDA-approved (Schedule II) in the US and Health Canada approved.
Adderall XR Sleep Architecture Impact: What the Clinical Evidence Shows
A clinical deep-dive into how Adderall XR (mixed amphetamine salts) alters sleep architecture, including REM suppression, sleep onset latency, and slow-wave sleep changes, with evidence-based management strategies.
Does TRICARE Cover Adderall XR? Coverage, Prior Auth, and Appeals Explained
Complete guide to TRICARE coverage for Adderall XR (mixed amphetamine salts): formulary tier, prior authorization criteria, step therapy requirements, appeal process, and cost options for active-duty and military families.
Adderall XR Microdosing Protocols: What the Evidence Actually Shows
A clinical review of Adderall XR (mixed amphetamine salts) microdosing protocols, standard dosing evidence, pharmacokinetics, and prescribing considerations backed by primary literature.
Florinef Uses, Dosing and Side Effects Explained
Florinef (fludrocortisone) treats adrenal insufficiency and salt-wasting CAH at 0.05-0.2 mg daily. See dosing, side effects, and how it differs from prednisone.
Cortef vs Prednisone: Dosing, Potency and Half-Life Compared
20mg hydrocortisone (Cortef) equals 5mg prednisone. Compare potency, half-life and dosing to see which suits replacement vs anti-inflammatory use.
Ketoconazole Cortisol Suppression in Cushing's Syndrome
Ketoconazole blocks adrenal cortisol synthesis, normalizing levels in 50-70% of patients; hepatotoxicity risk requires regular liver-function monitoring.
HPA Suppression from Steroids: Recovery Time and Treatment
HPA suppression from steroid use can last days to over 12 months. Learn causes, diagnostic tests, tapering steps, and when hydrocortisone is needed.
Tapering Prednisone Safely: An Evidence-Based Dose Reduction Guide
A complete guide to tapering prednisone safely, including dose reduction schedules, hydrocortisone replacement dosing, stress dose steroid protocols, and sick day rules for adrenal insufficiency.
AndroGel Geriatric (65+) Caregiver Administration Guidance
A complete clinical guide to AndroGel (testosterone gel 1% and 1.62%) caregiver administration for men 65 and older, covering application technique, transfer prevention, safety monitoring, and dose adjustment.
AndroGel in Men 65 and Older: What the Evidence Actually Shows
A guide to AndroGel (testosterone gel 1%/1.62%) use in men aged 65 and older, covering FDA labeling, off-label considerations, the TTrials findings, cardiovascular and hematologic risks, dosing, and monitoring protocols.
BPC-157 in Adults 65 and Older: Evidence and Dosing Gaps
What is known about BPC-157 in older adults? Examine geriatric evidence gaps, animal pharmacokinetics, kidney-function assumptions, and interaction claims.
Trulicity (Dulaglutide) for Adults 65 and Older: School, Work, and Activity Considerations
A clinical guide to using Trulicity (dulaglutide) safely in adults aged 65 and older, covering physical activity, cognitive engagement, fall risk, dosing schedules, and daily-life planning.
Trulicity (Dulaglutide) in Patients 65 and Older: Transitioning to Adult Care
A clinician-focused guide to using dulaglutide (Trulicity) in geriatric patients aged 65 and older, covering dose selection, safety considerations, renal function, polypharmacy, and care-transition planning.
Trulicity (Dulaglutide) in Children Under 12: Transition to Adult Care
A clinical guide to managing dulaglutide therapy in pediatric patients under age 12 with type 2 diabetes, covering FDA approval status, dosing, monitoring, and the structured transition to adult endocrinology care.
Avodart (Dutasteride) in Adults 65 and Older: School, Work, and Daily Activity Considerations
A guide to how dutasteride (Avodart) affects cognitive function, driving, physical activity, and daily scheduling in adults aged 65 and older, with primary-source citations throughout.
Enclomiphene Citrate in Men 65+: School, Work, and Daily Activity Considerations
A guide to how enclomiphene citrate affects cognitive performance, driving, exercise capacity, and daily activities in men aged 65 and older, with dosing context and safety data.
Epitalon for Adults 65 and Older: School, Learning, and Activity Considerations
A clinically grounded guide to epitalon use in adults aged 65 and older, covering cognitive engagement, physical activity compatibility, dosing considerations, and the telomere science behind this tetrapeptide.
Oral Estradiol for Patients 65+: Caregiver Administration Guidance
A guide for caregivers managing oral estradiol in patients aged 65 and older, covering dosing, safety monitoring, missed doses, swallowing difficulties, and when to call the prescriber.
Finasteride in Adults 65 and Older: School, Work, and Activity Considerations
A clinical guide to finasteride use in geriatric patients (65+), covering cognitive safety, physical activity interactions, driving, fall risk, and quality-of-life considerations backed by primary-source evidence.
Finasteride in Adults 65 and Older: Dosing, Safety, and Transition to Adult Care
A guide to finasteride use in geriatric patients (65+), covering pharmacokinetics, BPH and hair-loss dosing, drug interactions, PSA monitoring, sexual side-effect risk, and practical transition-of-care checklists.
Accutane (Isotretinoin) Geriatric (65+) Caregiver Administration Guidance
A guide for caregivers managing isotretinoin therapy in patients aged 65 and older, covering iPLEDGE requirements, dose adjustments, drug interactions, and monitoring protocols specific to the geriatric population.
Isotretinoin (Accutane) in Adults 65 and Older: What Geriatric Patients and Caregivers Need to Know
A clinically detailed guide to isotretinoin use in adults aged 65 and older, covering iPLEDGE enrollment, dose adjustments, drug interactions, organ-system monitoring, and the transition from pediatric or young-adult dermatology care to geriatric-focused management.
Liraglutide in Adults 65 and Older: Off-Label Use, Dosing, and Safety
A clinical review of off-label liraglutide use in geriatric patients (65+), covering evidence from major trials, age-specific dosing considerations, cardiovascular data, and safety signals unique to older adults.
Liraglutide in Adults 65 and Older: Managing the Transition from Geriatric to Adult Care
A clinical guide for patients and providers on using liraglutide (Victoza, Saxenda) in adults aged 65+, including dosing adjustments, safety considerations, and how to manage care transitions from geriatric to adult medicine.
Metformin for Adults 65 and Older: School, Cognitive Activity, and Physical Exercise Considerations
A clinical guide to metformin use in geriatric patients covering cognitive engagement, physical activity, exercise-related lactic acidosis risk, renal monitoring, and dose adjustments for adults 65 and older.
Mounjaro Geriatric (65+) Caregiver Administration Guidance
Step-by-step caregiver guidance for administering Mounjaro (tirzepatide) to adults aged 65 and older, including dose escalation, injection technique, hypoglycemia monitoring, and age-specific safety considerations.
Oral Minoxidil for Adults 65+: Caregiver Administration Guidance
A guide for caregivers managing low-dose oral minoxidil in adults aged 65 and older, covering dosing, fluid monitoring, fall risk, and when to call for help.
Ozempic for Adults 65 and Older: School, Activity, and Daily Life Considerations
A guide to semaglutide (Ozempic 0.5 to 2.0 mg) use in adults 65 and older, covering safe physical activity, cognitive engagement, fall risk, muscle preservation, and practical dose management.
Ozempic for Adults 65 and Older: Managing the Transition to Adult Care
A guide to semaglutide (Ozempic) use in geriatric patients aged 65+, covering dose adjustments, safety monitoring, transitional care handoffs, and evidence from SUSTAIN and SELECT trials.
Rybelsus in Adults 65 and Older: A Clinical Guide to Geriatric Use and Transition to Adult Care
A guide to prescribing oral semaglutide (Rybelsus) in patients aged 65 and older, covering dose titration, renal and cardiac considerations, fall-risk, and how to transition geriatric patients smoothly into standard adult-care protocols.
Saxenda (Liraglutide 3 mg) in Adults 65 and Older: A Clinical Guide to Safe Use and Care Transitions
A guide on starting, adjusting, and transitioning older adults (65+) from pediatric or young-adult obesity care to liraglutide 3 mg (Saxenda) therapy, with dosing tables, safety data, and evidence-based monitoring protocols.
Saxenda for Children Under 12: A Caregiver's Complete Administration Guide
Saxenda (liraglutide 3 mg) is not FDA-approved for children under 12. This guide explains the current evidence, regulatory status, off-label considerations, and safe injection technique so caregivers can have informed conversations with their child's prescribing physician.
Spironolactone for Acne in Adults 65 and Older: School, Work, and Activity Considerations
A guide covering how geriatric patients (65+) using spironolactone for acne can safely manage daily activities, physical exertion, hydration, fall risk, and drug interactions.
Spironolactone for Acne in Geriatric Patients (65+): Transition to Adult Care
A guide to spironolactone use for acne in patients aged 65 and older, covering pharmacokinetics, dosing adjustments, drug interactions, hyperkalemia risk, and how adult-care providers should manage this transition.
TB-500 in Adults 65 and Older: What Geriatric Patients Need to Know
Review TB-500 evidence for older adults, including the difference from full-length thymosin beta-4 and the limits of dosing, recovery, and safety claims.
Thymosin Alpha-1 Geriatric (65+): School and Activity Considerations
A guide to thymosin alpha-1 (thymalfasin) use in adults aged 65 and older, covering community programs, physical activity safety, cognitive engagement, and monitoring protocols specific to the geriatric patient.
Wegovy in Adults 65 and Older: Geriatric Developmental Impact, Safety, and Clinical Guidance
A comprehensive clinical review of semaglutide 2.4 mg (Wegovy) use in patients aged 65+, covering efficacy, muscle and bone loss risks, nutritional considerations, dose titration, and updated geriatric prescribing guidance.
Wegovy for Adults 65 and Older: What the Geriatric Transition to Adult Care Means for You
A clinically detailed guide to starting, continuing, or transitioning onto Wegovy (semaglutide 2.4 mg) in patients aged 65 and older, covering dosing, safety, muscle loss, polypharmacy, and what geriatric guidelines actually say.
Fosamax Hair and Skin Changes: What Alendronate Actually Does to Integument
A deep dive into alendronate (Fosamax) hair and skin side effects, including postmarketing case reports, mechanism, and clinical management guidance.
Fosamax Mental Health and Mood Impact: What the Evidence Actually Shows
A clinician-level review of alendronate (Fosamax) and its reported effects on mood, depression, anxiety, and cognitive function, with primary-literature citations and a practical monitoring framework.
Fosamax Safety for Adults Ages 50 to 64
Fosamax (alendronate) cuts vertebral fracture risk 47% in trials; watch for GI irritation, rare jaw issues, and femur fracture risk after 5+ years of use.
Fosamax Renal Protection or Renal Risk: What Clinicians Need to Know
A clinician-level review of alendronate (Fosamax) and the kidneys: pharmacokinetics, renal clearance, CKD dosing thresholds, evidence from FIT and post-market data, and practical monitoring guidance.
Fosamax Storage, Stability & Shelf Life: What Patients and Clinicians Need to Know
A guide to alendronate (Fosamax) storage conditions, shelf-life data, stability science, and what degradation means for fracture-risk protection.
Praluent Pre-Surgery Hold Window: How Long to Stop Alirocumab Before an Operation
Evidence-based guidance on when to pause alirocumab (Praluent) before surgery, covering pharmacokinetics, bleeding risk, lipid rebound, and restart timing for cardiovascular patients.
Alprostadil (Caverject/MUSE) Safety for Adults Aged 30 to 49
A guide to alprostadil safety in men aged 30 to 49, covering injection-site reactions, priapism risk, contraindications, dosing protocols, and how intracavernosal versus intraurethral delivery compare on the safety profile.
Alprostadil (Caverject/MUSE) Future Formulations & Pipeline
A clinician-level review of alprostadil's emerging delivery systems, combination approaches, and pipeline agents targeting refractory erectile dysfunction beyond the current intracavernosal and intraurethral formulations.
Alprostadil (Caverject/MUSE) Self-Injection Technique: A Complete Clinical Guide
Step-by-step alprostadil intracavernosal injection and MUSE urethral suppository technique, with dosing, mechanism, safety data from Linet et al. (NEJM 1996), and guidance for men with refractory erectile dysfunction.
Amlodipine Bone Health and Density Impact: What the Evidence Actually Shows
A clinical deep-dive into how amlodipine, a calcium channel blocker used for hypertension and angina, affects bone mineral density, fracture risk, osteoclast activity, and long-term skeletal outcomes, with primary-literature citations.
Amlodipine and Cognitive Function: What the Evidence Actually Shows
A clinician-level review of amlodipine's impact on cognitive function, covering ASCOT-BPLA, calcium-channel mechanisms, blood-pressure lowering effects on dementia risk, and practical prescribing guidance.
Amlodipine Liver Function Impact: What the Clinical Evidence Actually Shows
A deep dive into how amlodipine affects liver enzymes, hepatic metabolism, and safety in patients with liver disease. Includes primary-literature citations, dosing guidance, and clinical decision frameworks.
Amlodipine Monitoring Schedule: Labs, Exams, and What to Watch
Amlodipine monitoring requires no routine labs in most patients: check blood pressure, heart rate and ankle edema at 2-4 weeks, then every 3-6 months.
Amlodipine Safety for Adults Ages 50 to 64: What the Evidence Says
A guide to amlodipine safety in adults aged 50, 64, covering cardiovascular benefits, side-effect profile, drug interactions, perimenopause/andropause overlap, and practical dosing guidance backed by named trials and guidelines.
Amlodipine Pre-Surgery Hold Window: What Clinicians Need to Know
Evidence-based guidance on whether to hold or continue amlodipine before surgery, covering hemodynamic risks, guideline recommendations, anesthetic interactions, and clinical decision frameworks for perioperative management.